He, Y., Koch, R., Budamagunta, V., Zhang, P., Zhang, X., Khan, S., . . . Zhou, D. (2020). DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas. Journal of hematology and oncology, 13(1), 95-13. https://doi.org/10.1186/s13045-020-00928-9
Citácia podle Chicago (17th ed.)He, Yonghan, et al. "DT2216—a Bcl-xL-specific Degrader Is Highly Active Against Bcl-xL-dependent T Cell Lymphomas." Journal of Hematology and Oncology 13, no. 1 (2020): 95-13. https://doi.org/10.1186/s13045-020-00928-9.
Citácia podľa MLA (8th ed.)He, Yonghan, et al. "DT2216—a Bcl-xL-specific Degrader Is Highly Active Against Bcl-xL-dependent T Cell Lymphomas." Journal of Hematology and Oncology, vol. 13, no. 1, 2020, pp. 95-13, https://doi.org/10.1186/s13045-020-00928-9.